Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for China Pharma Holdings (CPHI) over the last 14 years, with Q3 2025 value amounting to $3.9 million.

  • China Pharma Holdings' Shares Outstanding (Weighted Average) rose 12384.86% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 12384.86%. This contributed to the annual value of $17.5 million for FY2024, which is 41613.26% up from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Shares Outstanding (Weighted Average) is $3.9 million, which was up 12384.86% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Shares Outstanding (Weighted Average) peaked at $46.0 million during Q3 2021, and registered a low of $1.1 million during Q4 2022.
  • For the 5-year period, China Pharma Holdings' Shares Outstanding (Weighted Average) averaged around $10.5 million, with its median value being $3.4 million (2023).
  • In the last 5 years, China Pharma Holdings' Shares Outstanding (Weighted Average) plummeted by 8960.76% in 2022 and then surged by 41613.26% in 2024.
  • Over the past 5 years, China Pharma Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $4.6 million in 2021, then tumbled by 77.21% to $1.1 million in 2022, then skyrocketed by 221.82% to $3.4 million in 2023, then soared by 416.13% to $17.5 million in 2024, then tumbled by 77.82% to $3.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $3.9 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.3 million in Q1 2025.